Jaguar Health, Inc. (JAGX) Stock Price, News, Quote & History - Yahoo Finance
Oops, something went wrong
Skip to navigation
Skip to main content
Skip to right column
News
Today's news
US
Politics
World
Weather
Climate change
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Science
Originals
The 360
Newsletters
Games
Life
Health
Wellness
Nutrition Fitness Healthy aging Mental health Sleep
Your body
Dermatology Children's health Foot health Hair loss Hearing Oral health Sexual health Women’s health
Conditions
Cardiovascular health Digestive health Endocrine system
Parenting
Family health
So mini ways
Style and beauty
It Figures
Unapologetically
Horoscopes
Shopping
Style
Accessories Clothing Luggage Shoes
Beauty
Hair Makeup Skincare Sunscreen
Health
Dental Fitness Hair loss Hearing aids Mental health Mobility Nutrition Personal care Sleep Women's health
Home and garden
Bedding Cleaning Gardening Kitchen Outdoor
Pets
Tech
Accessories Audio Auto Computers Phones Smart home TVs
Gift ideas
Stores
Amazon Best Buy Home Depot Macy's Nordstrom Target Walmart Wayfair
Shopping Guides
Best non-toxic cutting boards Best heated socks Best body wash Best cordless stick vacuums Best makeup removers
Deals
Food
Travel
Autos
EV & Future Tech
Classic & Collector
Deals & Buying Guides
Ownership
Safety & Recalls
Policy & Environment
New Vehicles & Reviews
Auto Shows
General
People & Culture
Gift ideas
Buying guides
Best Prime Day deals
Prime Day tech deals
October Prime Day deals
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My Portfolio
News
Latest
Stock Market
Originals
Crypto
Tariff Updates
Newsletters
Economies
Premium News
Earnings
Tech
Housing
Markets
Stocks: Most Actives
Stocks: Gainers
Stocks: Losers
Trending Tickers
Futures
World Indices
US Treasury Bonds Rates
Currencies
Crypto
Top ETFs
Top Mutual Funds
Options: Highest Open Interest
Options: Highest Implied Volatility
Sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Private Companies
Research
Screeners
Earnings Calendar
Economic Calendar
Stock Comparison
Advanced Chart
Currency Converter
Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards
Banking
Student Loans
Personal Loans
Insurance
Mortgages
Mortgage Calculator
Taxes
Videos
Latest
Trending Stocks
Market Sunrise
Morning Brief
Opening Bid
All Shows
Stocks in Translation
Trader Talk
Financial Freestyle
ETF Report
FA Corner
Options Playbook
Watch Now
Sports
Fantasy
News
Fantasy football
Best ball
Pro Pick 'Em
College Pick 'Em
Fantasy baseball
Fantasy hockey
Fantasy basketball
Download the app
Daily fantasy
NFL
News
Scores and schedules
Standings
Stats
Teams
Players
Drafts
Injuries
Odds
Super Bowl
GameChannel
Videos
NBA
News
Draft
Scores and schedules
Standings
Stats
Teams
Players
Injuries
Videos
Odds
Playoffs
MLB
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Videos
World Baseball Classic
NHL
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Playoffs
College football
News
Scores and schedules
Standings
Rankings
Stats
Teams
College basketball
Soccer
News
Scores and schedules
Premier League
MLS
NWSL
Liga MX
CONCACAF League
Champions League
La Liga
Serie A
Bundesliga
Ligue 1
World Cup
NFL Draft
Yahoo Sports AM
Show all
WNBA
Sportsbook
NCAAF
Tennis
Golf
NASCAR
NCAAB
NCAAW
Boxing
USFL
Cycling
Motorsports
Olympics
Horse racing
GameChannel
Rivals
Newsletters
Podcasts
Videos
RSS
Jobs
Help
World Cup
More news
New on Yahoo
Creators
Tech
Audio
Computing
Gaming
Connections Gaming deals Nintendo PC PlayStation Wordle Xbox
Home entertainment
TVs
Phones
Science
Streaming
Streaming reviews
Tech News
VPN
Deals
More
AI Apps AR and VR Business Cameras Cyber security Entertainment General Reviews and guides Smart home Social media Transportation Wearables
Local services
Moving
Roofing
Painting
Plumbing
Terms
Privacy
Privacy Dashboard
Feedback
© 2025
All rights reserved.
About our ads
Advertising
Careers
Yahoo Finance
Yahoo Finance
Search query
Select edition
USEnglish
US y LATAMEspañol
AustraliaEnglish
CanadaEnglish
CanadaFrançais
DeutschlandDeutsch
FranceFrançais
香港繁中
MalaysiaEnglish
New ZealandEnglish
SingaporeEnglish
台灣繁中
UKEnglish
News
Finance
Sports
More
News
Today's news
US
Politics
World
Weather
Climate change
Health
Science
Originals
Newsletters
Games
Life
Health
Parenting
Style and beauty
Horoscopes
Shopping
Food
Travel
Autos
Gift ideas
Buying guides
Best Prime Day deals
Prime Day tech deals
October Prime Day deals
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My portfolio
Watchlists
Markets
News
Videos
Screeners
Personal finance
Crypto
Sectors
Sports
Fantasy
NFL
NBA
MLB
NHL
College football
College basketball
Soccer
NFL Draft
Yahoo Sports AM
New on Yahoo Creators Tech Local services
Selected edition
USEnglish
Mail
Sign in
My Portfolio
News
Latest Stock Market Originals Crypto Tariff Updates Newsletters Economies Premium News
Earnings Tech Housing
Markets
Stocks: Most Actives Stocks: Gainers Stocks: Losers Trending Tickers Futures World Indices US Treasury Bonds Rates Currencies Crypto Top ETFs Top Mutual Funds Options: Highest Open Interest Options: Highest Implied Volatility Sectors Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities Private Companies
Research
Screeners Earnings Calendar Economic Calendar Stock Comparison Advanced Chart Currency Converter Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards Banking Student Loans Personal Loans Insurance Mortgages Mortgage Calculator Taxes
Videos
Latest Trending Stocks Market Sunrise Morning Brief Opening Bid All Shows Stocks in Translation Trader Talk Financial Freestyle ETF Report FA Corner Options Playbook
Watch Now
…
Upgrade to Premium
JAGX Jaguar Health, Inc.
2.0200
+0.50%
Summary
News
Research
Chart
Community
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
We are experiencing some temporary issues. The market data on this page is currently delayed.
NasdaqCM - Nasdaq Real Time Price • USD
Jaguar Health, Inc. (JAGX)
Follow
Add holdings
Get top stock picks
2.0200
+0.0100
+(0.50%)
As of 1:22:05 PM EDT. Market Open.
Get top stock picks
Chart Range Bar
1D
5D
8.60%
1M
12.22%
6M
-66.56%
YTD
-92.00%
1Y
-92.59%
5Y
-100.00%
All
-100.00%
Key Events
Mountain
Advanced Chart
Loading chart for JAGX
Previous Close 2.0100
Open 2.0200
Bid 1.4800 x 200
Ask 2.4700 x 200
Day's Range 1.9100 - 2.0800
52 Week Range 1.5700 - 35.2500
Volume 877,999
Avg. Volume 108,620
Market Cap (intraday) 4.393M
Beta (5Y Monthly) 0.60
PE Ratio (TTM) 0.05
EPS (TTM) 37.5300
Earnings Date Nov 13, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 28.00
Jaguar Health, Inc. Overview Biotechnology / Healthcare
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California. jaguar.health
49 Full Time Employees December 31 Fiscal Year Ends Healthcare
Sector Biotechnology
Industry
More about Jaguar Health, Inc.
Recent News: JAGX View More
All
News
Earnings Calls
Press Releases
SEC Filings
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
ACCESS Newswire • 4h ago
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
GlobeNewswire • 6h ago
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
ACCESS Newswire • 1d ago
Jaguar Health Completes Private Placement Deal
Insider Monkey • 3d ago
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts
ACCESS Newswire • 19d ago
Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs
ACCESS Newswire • 1mo ago
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
ACCESS Newswire • 1mo ago
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
ACCESS Newswire • 1mo ago
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
GlobeNewswire • 1mo ago
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
ACCESS Newswire • 1mo ago
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
ACCESS Newswire • 1mo ago
View More
Performance Overview: JAGX
Trailing total returns as of 9/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC)
.
YTD Return
JAGX 92.00%
S&P 500 (^GSPC) 12.83%
1-Year Return
JAGX 92.59%
S&P 500 (^GSPC) 15.75%
3-Year Return
JAGX 99.99%
S&P 500 (^GSPC) 79.68%
5-Year Return
JAGX 100.00%
S&P 500 (^GSPC) 104.40%
Compare To: JAGX Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
JAGX Jaguar Health, Inc.
2.0200 +0.50%
Mkt Cap
4.393M
Industry Biotechnology
IBIO iBio, Inc.
0.8295 +4.04%
Mkt Cap
16.304M
Industry Biotechnology
OGEN Oragenics, Inc.
1.3200 -2.22%
Mkt Cap
5.448M
Industry Biotechnology
ADTX Aditxt, Inc.
1.0100 -0.98%
Mkt Cap
5.026M
Industry Biotechnology
VXRT Vaxart, Inc.
0.3650 -4.74%
Mkt Cap
83.555M
Industry Biotechnology
TNXP Tonix Pharmaceuticals Holding Corp.
25.05 -0.95%
Mkt Cap
219.586M
Industry Biotechnology
DYAI Dyadic International, Inc.
1.1250 +4.17%
Mkt Cap
40.711M
Industry Biotechnology
AIM AIM ImmunoTech Inc.
2.6800 +1.32%
Mkt Cap
7.259M
Industry Biotechnology
BDRX Biodexa Pharmaceuticals Plc
6.71 +6.51%
Mkt Cap
4.157M
Industry Biotechnology
PALI Palisade Bio, Inc.
0.6800 +7.53%
Mkt Cap
6.337M
Industry Biotechnology
OCGN Ocugen, Inc.
1.7400 +4.82%
Mkt Cap
543.41M
Industry Biotechnology
Statistics: JAGX View More
Valuation Measures
Current
Quarterly
Annual
As of 9/23/2025 Market Cap
4.37M
Enterprise Value
35.18M
Trailing P/E
0.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales
(ttm) 0.11
Price/Book
(mrq) 0.79
Enterprise Value/Revenue
2.98
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets
(ttm) -37.42%
Return on Equity
(ttm) -319.25%
Revenue
(ttm) 11.81M
Net Income Avi to Common
(ttm) -40.65M
Diluted EPS
(ttm) 37.5300
Balance Sheet and Cash Flow
Total Cash
(mrq) 2.21M
Total Debt/Equity
(mrq) 443.75%
Levered Free Cash Flow
(ttm) -16.04M
View More
Research Analysis: JAGX View More
Earnings Per Share
Consensus EPS
Revenue vs. Earnings
Revenue 2.98M
Earnings -7.52M
Q324
Q424
Q125
Q225
-10M
-5M
0
Analyst Recommendations
Strong Buy
Buy
Hold
Underperform
Sell
Analyst Price Targets
16.00
28.00 Average
2.0200 Current
40.00 High
View More
Company Insights: JAGX
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn More
2.0200 Current
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
0 Low
Sector Avg.
100 High
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
0 Low
Sector Avg.
100 High
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
0 Low
Sector Avg.
100 High
People Also Watch
OCGN
Ocugen, Inc.
1.7400 +4.82%
BNGO
Bionano Genomics, Inc.
1.7050 +1.49%
TNXP
Tonix Pharmaceuticals Holding Corp.
25.05 -0.95%
CHEK
Check-Cap Ltd.
2.1150 -5.79%
CTRM
Castor Maritime Inc.
2.2173 +0.33%
Copyright © 2025 Yahoo. All rights reserved.
What's trending Dow Jones
S&P 500
DAX Index
Nvidia
Tesla
DJT
Tariffs
Explore more Mortgages
Credit Cards
Sectors
Crypto Heatmap
Financial News
About Data Disclaimer
Help
Feedback
Sitemap
Licensing
What's New
About Our Ads
Premium Plans
Terms
and Privacy Policy
Privacy Dashboard
More Info
U.S. markets close in 2h 38m
US
Europe
Asia
Cryptocurrencies
Rates
Commodities
Currencies
S&P 500
6,636.01 -20.91 (-0.31%)
Dow 30
46,184.42 -108.36 (-0.23%)
Nasdaq
22,477.49 -95.98 (-0.43%)
Russell 2000
2,445.43 -12.08 (-0.49%)
VIX
16.98 +0.34 (+2.04%)
Gold
3,770.90 -44.80 (-1.17%)
Portfolio
Portfolio
Sign in to access your portfolio Sign in
Top gainers
QURE uniQure N.V. 46.01 +32.35 (+234.85%)
CDTX Cidara Therapeutics, Inc. 89.44 +15.95 (+21.70%)
IREN IREN Limited 48.59 +6.81 (+16.32%)
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.29%)
VNET VNET Group, Inc. 10.73 +1.38 (+14.71%)
Top losers
FCX Freeport-McMoRan Inc. 38.73 -6.63 (-14.61%)
WOR Worthington Enterprises, Inc. 51.70 -8.56 (-14.21%)
BE Bloom Energy Corporation 66.99 -10.39 (-13.43%)
BGM BGM Group Ltd. 10.23 -1.52 (-12.93%)
MENS Jyong Biotech Ltd. 55.82 -6.18 (-10.00%)
Most active
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.29%)
PLUG Plug Power Inc. 2.4309 -0.0991 (-3.92%)
RGTI Rigetti Computing, Inc. 33.74 +2.30 (+7.30%)
NVDA NVIDIA Corporation 176.98 -1.45 (-0.81%)
SNAP Snap Inc. 8.25 -0.17 (-1.97%)
Earnings events
My earnings events
Earnings events
Trending tickers
LAC Lithium Americas Corp. 6.09 +3.02 (+98.15%)
BABA Alibaba Group Holding Limited 176.74 +13.65 (+8.37%)
QURE uniQure N.V. 46.12 +32.46 (+237.59%)
IREN IREN Limited 48.60 +6.83 (+16.34%)
HOOD Robinhood Markets, Inc. 127.85 +1.65 (+1.31%)
Top economic events
Top economic events
United States
Mortgage Market Index
Sep 24, 2025, 7:00 AM EDT Prior: P: 386.1 New: N: 388.3
Mortgage Market Index
Sep 24, 2025, 7:00 AM EDT Prior: Prior: 386.1 New: New: 388.3
MBA 30-Yr Mortgage Rate
Sep 24, 2025, 7:00 AM EDT Prior: P: 6.39 New: N: 6.34
MBA 30-Yr Mortgage Rate
Sep 24, 2025, 7:00 AM EDT Prior: Prior: 6.39 New: New: 6.34
Edit your Dock
Terms
and Privacy Policy
Privacy Dashboard
Ad Terms
Feedback
More Info